From Conjecture to Clarity

Supporting the Healthcare Industry
with Local Industry Knowledge
and Marketing Expertise

Our Offerings

Pharmaceutical Sales Forecast & Project Valuation

Our clients are industry leaders who would like to make well-informed decisions about entering markets.

We help clients understand the Japanese market, recognize threats and opportunities and provide a clear idea of the value of their innovation in Japan.

Our services include

  • Forecasting models
  • P&L assumptions
  • Primary market research
  • Competitive landscape
  • Pricing Assumptions
Click here for details >

Pharmaceutical Pricing Consultation

The pricing of pharmaceuticals always presents a challenge for companies seeking to expand their footprint in new markets.

We provide a full range of pricing and market access consultations from the planning stage to post-commercialization.

Our clients are able to develop fully integrated global pricing strategies to maximize the value of their product.

Our services include

  • Forecasting Price Dynamics of New & Existing Products
  • Consultation, Participation and Representation in the Official Price Negotiation Process
  • In-Depth Interviews with MLHW Officials
Click here for details >

Business Development Support

We support clients seeking to partner with Japanese companies.

e-Projection’s deep engagement in the industry network space differentiates us from any other vendor of the kind.

We are widely recognized for our knowledge of the local market and support the negation process by quantifying the value of the asset in a convincing manner.

We also have a network in China and can support those clients who additionally want to partner with Chinese companies.

Our services include

  • Target Screening & Identification
  • Approach to Initiate Communication
  • Due Diligence
  • Term Sheet Negotiation
  • Approach to Initiate Communication
  • Alliance Management
Click here for details >

We help non-Japanese pharma/biotech companies understand and expand into the Japanese market.

Blog

  • 2021.10.07
    blog-en

    e-Projection will deliver a lecture at Tokyo University of Science, Management of Technology

    Tokyo University of science, Management of Technology is holding various seminars and Symposiums in order to promote the talent development in the field of management of technology. It is our honor to announce that our CEO, Tosh Nagate will deliver a lecture as a guest speaker there on “Sales forecast for pharmaceutical products and project valuation” . Not only […]

  • 2021.10.06
    blog-en

    e-Projection is going to Bio Japan in Yokohama

    e-Projection is participating in the BioJapan, which is a part of Asia’s largest partnering event. This event is constituted by three exhibitions – 1. The world’s oldest biotechnology exhibition “BioJapan”,  2. “Regenerative Medicine JAPAN”, aiming to accelerate and industrialize R&D in the field of regenerative medicine including iPS cells, and 3.”health TECH JAPAN”, provides fusion […]

  • 2021.09.13
    blog-en

    Post event report: Online seminar “Update on the valuation of pharmaceuticals in the Covid-19 world”

    e-Projection held an online seminar on September 10th, 2021. This seminar titled “Update on the valuation of pharmaceuticals in the Covid-19 world ” brought together more than 100 representatives from Japanese pharmaceutical companies.   The speaker this time was our CEO, Toshi Nagate and he spoke about the valuation of development project from comprehensive aspect […]

  • 2021.08.24
    blog-en

    New Drugs Added to NHI Price List on August 12

    The Central Social Insurance Medical Council (Chuikyo), an advisory board for the reimbursement system relating to public healthcare insurance, endorsed the listing of 23 new drugs with 15 ingredients at its general meeting on August 4. These new joined the NHI price list on August 12, including Chugai Pharmaceutical’s Evrysdi (risdiplam), which marks the first […]

  • 2021.05.24
    blog-en

    To Be, or Not to Be in Japan, That is the Problem

    Consider involving Japan in your drug development program, and start thinking about it now Globalization in the pharmaceutical industry is an ongoing and never ending process due to the monotonically increasing desire of people all over the world to gain faster access to healthcare innovation, fueled by the tireless efforts of the drug manufacturers to […]

We help non-Japanese pharma/biotech companies understand and expand into the Japanese market.